Molecular Diagnostics Market: Opportunities and Challenges

Molecular Diagnostics Market: Opportunities and Challenges

The key players in the global market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US). These players focus on inorganic strategies such as acquisitions, partnerships, agreements, and collaborations as well as organic strategies such as expansions and product launches & approvals to sustain their positions in the market.
The global molecular diagnostics market is projected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4% during the forecast period.

The global molecular diagnostics market is projected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4% during the forecast period.

How do advances in genomics and proteomics create opportunities for players in the molecular diagnostics market?

Advances in genomics and proteomics have resulted in the development of a multitude of assays and technologies useful for the diagnosis and management of diseases. The new technologies, based on genomics techniques such as PCR and proteomics, help in the discovery of new molecular diagnostics approaches for disease diagnosis and disease pathogenesis. They also enable better surveillance and rapid diagnosis.

Download PDF Brochure:

Genomics and proteomics are research-driven sectors. Thus, advanced technologies developed through combined efforts by pharmaceutical research companies, the medical community, and government agencies can help combat the threat posed by various infections and cancers. The availability of funds from organizations such as the National Institutes of Health (NIH) and the National Science Foundation (NSF) for various projects has resulted in an increase in the number of research activities in these fields. With growing research in proteomics and genomics, the commercialization of more advanced molecular diagnostics techniques is expected in the coming years.

Will the dearth of trained professionals limit the appropriate use of new molecular diagnostics technologies?

The knowledge of molecular diagnostics technologies is vital for effectively carrying out molecular diagnostics tests. Molecular assays are sensitive to the quantity and purity of the samples used, and small deviations can lead to erroneous and variable inferences. In addition, different and complex types of platforms, instruments, and laboratory documentation systems are used in the MDx field. Clinical microbiology laboratories across major markets are still evolving, and their technicians face operational challenges for sample procurement, storage, and transportation, especially while adopting novel technologies such as NGS and lab-on-a-chip PCR devices.

Furthermore, due to the rapid mutation of microbes and the increasing outbreak of epidemics, clinical laboratories need to adopt innovative technologies capable of rapid sample diagnosis. Hence, it is mandatory that all laboratories and setups are well-versed with the technologies in order to begin practice. Well-qualified and skilled personnel with special training are required for the effective analysis of solutions. As the level of awareness about the latest advancements in molecular tests is low among a number of clinicians, it is resulting in an operational gap for clinical laboratories, and the uptake of such technologies is largely restricted. Thus, the dearth of skilled, well-trained, and technically knowledgeable laboratory technicians to operate advanced molecular diagnostics products is limiting their overall adoption, particularly in emerging markets.

Request Sample Pages:

Browse Related Reports:

Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) – Global Forecast to 2022

Influenza Diagnostics Market by Test type (Molecular (RT-PCR, NASBA, LAMP, SAMBA), Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test)), End user (Hospital, Clinic, Reference lab, POC, Home Care Agency) – Global Forecast to 2021

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States